Skip to main content

Table 3 Outcomes in patients with and without barotrauma

From: Barotrauma in COVID-19 acute respiratory distress syndrome: retrospective analysis of the COVADIS prospective multicenter observational database

 

Barotrauma

N = 48

No barotrauma

N = 536

P value

Renal replacement therapy, n (%)

33 (68.7)

316 (58.9)

0.18

Creatinine peak, µmol/l, median [IQR]

164 [114–340]

131 [79–319]

 

Acute cardiac injury, n (%)

8 (16.6)

6 (1.1)

0.14

Vasopressors during ICU stay, n (%)

43 (89.6)

433 (80.7)

0.13

Pulmonary embolism, n (%)

12 (25.0)

58 (10.8)

0.004

Deep vein thrombosis, n (%)

3 (6.2)

34 (6.3)

0.98

ICU discharge alive, n (%)

16 (33.3)

291 (54.2)

0.005

eMV duration, days, median [IQR]

19 [11–33]

14 [8–24]

0.01

ICU stay length, days, median [IQR]

20 [12–36]

18 [10–29]

0.09

Hospital discharge alive, n (%)

13 (27.0)

289 (53.9)

< 0.001

Hospital stay length, days, median [IQR]

22 [13–43]

22 [12–38]

0.54

  1. ICU: intensive care unit; eMV: endotracheal mechanical ventilation